Goldman Sachs Talks

Amicus Therapeutics CEO John Crowley

06.04.2021 - By Goldman SachsPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.

More episodes from Goldman Sachs Talks